New material could make breast reconstruction safer and better

NCT ID NCT06456554

Recruiting now Disease control Sponsor: RTI Surgical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a special material (acellular dermal matrix) used in a two-stage breast reconstruction procedure for women who have had a mastectomy. The goal is to see if it reduces complications like infections or the need for extra surgeries, and improves quality of life. About 467 women will take part across multiple centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST RECONSTRUCTION

Contacts and locations

Locations

City of Hope National Medical Center
RECRUITING

Duarte, California, 91010, United States
Cleveland Clinic
RECRUITING

Cleveland, Ohio, 44195, United States
MD Anderson
RECRUITING

Houston, Texas, 77030, United States
Mercy
RECRUITING

Oklahoma City, Oklahoma, 73120, United States
Mercy Hospital
RECRUITING

St Louis, Missouri, 63141, United States
Mercy Hospital
NOT_YET_RECRUITING

Oklahoma City, Oklahoma, 73120, United States
NYU Langone Health
RECRUITING

New York, New York, 10016, United States
New York Presbyterian Hospital/Columbia University Irving Medical Center
RECRUITING

New York, New York, 10032, United States
University of Arkansas
RECRUITING

Little Rock, Arkansas, 72205, United States
University of Colorado
RECRUITING

Aurora, Colorado, 80045, United States
University of Kansas
RECRUITING

Lawrence, Kansas, 66045, United States
University of Pennsylvania
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Washington University
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.